Joshua Reed

Chief Financial Officer, Aldeyra Therapeutics, Inc.

Companies

AlkermesChief financial officer Sep 23, 2025 to now¹
Scholar Rock Holding CorpBoard member Mar 18, 2021 to now²
Omega Therapeutics, Inc.Chief financial officer Jun 2, 2022 to Feb 9, 2024³
Aldeyra Therapeutics, Inc.Chief financial officer Aug 1, 2018 to Apr 1, 2022⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Scholar Rock Holding Corp SRRK19,518 shares⁵$795.9K at $40.78Jul 1, 2026
Aldeyra Therapeutics, Inc. ALDX274,825 shares⁶$209.1K at $0.76Mar 30, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 1, 2026Sold 948 shares at $54.28 of Scholar Rock Holding Corp⁵
Jul 1, 2026Sold 2,105 shares at $53.50 of Scholar Rock Holding Corp⁵
Jun 4, 2026Granted 6,839 shares of Scholar Rock Holding Corp⁷
May 29, 2025Sold 500 shares at $30.04 of Scholar Rock Holding Corp⁸
May 29, 2025Sold 4,900 shares at $29.68 of Scholar Rock Holding Corp⁸
May 22, 2025Granted 7,632 shares of Scholar Rock Holding Corp⁹
Jun 27, 2024Granted 13,500 shares of Scholar Rock Holding Corp¹⁰
Mar 30, 2022Granted 93,322 shares of Aldeyra Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAlkermes, Chief financial officer
2
SEC EDGARScholar Rock Holding Corp, Board member
3
SEC EDGAROmega Therapeutics, Inc., Chief financial officer
4
SEC EDGARAldeyra Therapeutics, Inc., Chief financial officer
5
SEC EDGARScholar Rock Holding Corp shares after the filing of Jul 1, 2026
6
SEC EDGARAldeyra Therapeutics, Inc. shares after the filing of Mar 30, 2022
7
SEC EDGARForm 4 filed Jun 8, 2026
8
SEC EDGARForm 4 filed May 30, 2025
9
SEC EDGARForm 4 filed May 23, 2025
10
SEC EDGARForm 4 filed Jul 1, 2024